SLC30A3 as a Zinc Transporter-Related Biomarker and Potential Therapeutic Target in Alzheimer’s Disease
Our study systematically identifies <i>SLC30A3</i> as a novel biomarker in AD, linking zinc dyshomeostasis to synaptic failure, metabolic impairment, and neuroimmune dysregulation. These findings offer a new basis for developing targeted diagnostic and therapeutic strategies for AD.
Authors
- Yong Diao (ORCID: https://orcid.org/0000-0002-0633-1906)
- Zhiyun Cheng
- Ruyu Bai
Institutions
- Huaqiao University (CN)
Publication Details
- Journal
- Genes
- Published
- 2025-11-13
- DOI
- https://doi.org/10.3390/genes16111380
- Citations
- 1
- Primary Topic
- Trace Elements in Health
- Type
- article
- Field-Weighted Citation Impact
- 1.12